Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC

Patients with HCC undergoing Atezo/Bev treatment, diagnosed with PD-multiple (not solely based on IH or EHS) or PD-MVI, experienced poor prognosis, specifically in terms of OS.

Authors

Institutions

Publication Details

Journal
Journal of Gastroenterology and Hepatology
Published
2025-01-22
DOI
https://doi.org/10.1111/jgh.16884
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC

Hideko Ohama, Norio Itokawa, Joji Tani, Kazunari Tanaka et al.
1 links
Journal of Gastroenterology and Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
article

Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC

Hideko Ohama, Norio Itokawa, Joji Tani, Kazunari Tanaka, Tomomitsu Matono, Kazuhito Kawata, Kazuya Kariyama, Hidenori Toyoda, Hirayuki Enomoto, Kazuhiro Nouso, Takeshi Hatanaka, Masatoshi Kudo, Yoichi Hiasa, Atsushi Hiraoka, Takashi Kumada, Yoshiko Nakamura, Shinya Fukunishi, Tomomi Okubo, Takuya Nagano, Ei Itobayashi, Masaki Kaibori, Masashi Hirooka, Chikara Ogawa, Hiroki Nishikawa, Hisashi Kosaka, Kazuto Tajiri, Takashi Nishimura, Toshifumi Tada, Atsushi Naganuma, Akemi Tsutsui, Hidekatsu Kuroda, Toru Ishikawa, Yutaka Yata, Masanori Atsukawa, Yuichi Koshiyama, Tomoko Aoki, Fujimasa Tada, Asahiro Morishita, Koichi Takaguchi, Michitaka Imai, Satoru Kakizaki, Osamu Yoshida, Taeang Arai, Shinichiro Nakamura, Kunihiko Tsuji
article en

Abstract

Patients with HCC undergoing Atezo/Bev treatment, diagnosed with PD-multiple (not solely based on IH or EHS) or PD-MVI, experienced poor prognosis, specifically in terms of OS.

Journal of Gastroenterology and HepatologyVol. 40(4)
Kansai Medical University (JP), Iwate Medical University (JP), Kagawa University (JP), Hamamatsu University School of Medicine (JP), Takamatsu Red Cross Hospital (JP), Saiseikai Niigata Daini Hospital (JP), National Hospital Organization Takasaki Medical Center (JP), Okayama Prefecture (JP), Ogaki Municipal Hospital (JP), Himeji Medical Center (JP), Hanwa Memorial Hospital (JP), Gunma Saiseikai Maebashi Hospital (JP), Himeji Red Cross Hospital (JP), Teine Keijinkai Hospital (JP), Asahi General Hospital (JP), Toyama University Hospital (JP), Ehime Prefectural Central Hospital (JP), Kagawa Prefectural Central Hospital (JP), Takarazuka City Hospital (JP), Ehime University (JP), Gifu Kyoritsu University (JP), Kobe University (JP), Nippon Medical School (JP), Hyogo University (JP), Osaka University of Pharmaceutical Sciences (JP), Kindai University (JP)
Openalex Percentile: Top 98%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.